Oksana Koneva

CVC and GBL clear path to delist Recordati after topping 90% stake

CVC and GBL clear path to delist Recordati after topping 90% stake
Recordati delisting nears

An investor consortium targeting Italian drugmaker Recordati has moved above the ownership threshold needed to take the company off the stock market. The holding reaches 91.9% after additional shares were tendered at the end of the offer period, based on Borsa Italiana data and Reuters calculations.

Highlights

  • CVC and GBL secure 91.9% of Recordati's shares at the end of the offer, exceeding the 90% delisting threshold.
  • The offer closed at 1630 GMT on Monday with a price of 53 euros per share, excluding additional market purchases on the same day.
  • Recordati is valued at about 11 billion euros ($12.32 billion), and delisting from the Milan market strengthens CVC and GBL's control.

Takeover offer reaches delisting threshold

As reported by Reuters, private equity firm CVC and Belgian investment group GBL secure more than 90% of Recordati at the end of the takeover offer period, clearing the way for the Italian pharmaceutical company to be delisted.

The additional shares tendered on Monday lift the consortium's holding above the 90% threshold required for delisting. The offer closes at 1630 GMT on Monday, with CVC and GBL offering 53 euros per share.

Following the close of the offer, the consortium's stake rises to 91.9%, according to Reuters calculations based on Borsa Italiana data. The figure does not include any shares acquired on the market by CVC or GBL on Monday.

Implications for Recordati and the Italian market

Crossing the 90% threshold gives the bidders a clear route to remove Recordati from the Milan market, marking a significant step in one of the larger transactions in Italy's pharmaceutical sector.

Recordati is valued at about 11 billion euros, or $12.32 billion, in the offer context. The outcome strengthens CVC and GBL's control over the drugmaker and advances the transaction from takeover execution toward a change in listing status.

Earlier, we reported that Fairfax Financial Holdings was offering around Rs 52,878 crore for the IDBI Bank stake sale in India.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.